CAMP4 THERAPEUTICS CORPORATION (CAMP NASDAQ) stock market data APIs
$3.2932
0.62(18.8%)
as of July 20, 2026
Try our APIs with
free plan!
CAMP4 THERAPEUTICS CORPORATION Financial Data Overview
Price chart is built with
Anychart
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Prev. Close
3.2932
Open
3.914
High
3.9687
Low
3.0234
52 wk Range
1.32-7.75
Market Cap
193 M
Shares Outstanding
51 926 K
Revenue
3 934 K
EPS
-0.21
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with CAMP4 THERAPEUTICS CORPORATION (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CAMP4 THERAPEUTICS CORPORATION data using free add-ons & libraries
Get CAMP4 THERAPEUTICS CORPORATION Fundamental Data
CAMP4 THERAPEUTICS CORPORATION Fundamental data includes:
- Net Revenue: 3 934 K
- EBITDA: -50 294 000
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get CAMP4 THERAPEUTICS CORPORATION Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-05-07
- EPS/Forecast: -0.21
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CAMP4 THERAPEUTICS CORPORATION News
New
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline...
New Strong Sell Stocks for July 16th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Albemarle ALB is a premier specialty chemicals company with leading positions in attractive end markets globally. The Zacks ...
New Strong Sell Stocks for July 16th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Aytu BioPharma, Inc. AYTU is a pharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been r...
Is CAMP4 THERAPEUTICS CORPORATION (CAMP) Stock Undervalued Ahead of Key CMP-002 Clinical Development Milestones?
We recently compiled a list of the 8 Best Up and Coming Pharmaceutical Stocks to Buy Now. CAMP4 THERAPEUTICS CORPORATION (NASDAQ:CAMP) is one of the best up and coming stocks on our list. TheFly repo...
Get CAMP4 THERAPEUTICS CORPORATION fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
